Peri-Implantitis: Diagnosis, Risk Factors, and Surgical Management

Peri-implantitis has emerged as one of the most significant complications in implant dentistry, affecting an estimated 20% of patients and 10% of implants at the patient and implant levels respectively. As the global population of dental implants grows, the burden of peri-implant disease is expanding proportionally, making its diagnosis and management a critical competency for dental practitioners.

Definitions and Diagnostic Criteria

The 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions established standardized definitions that remain the current consensus. Peri-implant health is characterized by the absence of erythema, bleeding on probing (BOP), swelling, and suppuration, with no progressive bone loss beyond initial crestal bone remodeling.

Peri-implant mucositis is defined as an inflammatory lesion confined to the soft tissues surrounding an implant, characterized by BOP and/or suppuration, with or without increased probing depths compared to baseline. Crucially, mucositis occurs in the absence of progressive bone loss beyond crestal bone remodeling. It is the precursor lesion to peri-implantitis but is reversible with appropriate treatment.

Peri-implantitis is a plaque-associated pathologic condition occurring in tissues around dental implants, characterized by inflammation of the peri-implant mucosa and progressive loss of supporting bone. The diagnostic criteria include: BOP and/or suppuration on gentle probing, increased probing depth compared to previous examinations, and progressive bone loss on radiographs beyond the initial crestal bone level changes resulting from remodeling.

In the absence of baseline radiographs, a threshold of 3 mm or more of bone loss from the implant platform, combined with BOP and probing depths of 6 mm or greater, is considered diagnostic. It is essential to emphasize that bone loss alone is insufficient for diagnosis; the presence of clinical signs of inflammation is required to differentiate peri-implantitis from stable peri-implant bone levels or non-inflammatory bone loss.

Prevalence and Natural History

Prevalence estimates for peri-implantitis vary substantially depending on the diagnostic threshold, population, and follow-up period. Systematic reviews suggest patient-level prevalence of 18-24% and implant-level prevalence of 9-12% when using the more conservative 2017 workshop criteria. When less stringent criteria are applied, prevalence estimates can reach 30-40%.

The natural history of peri-implantitis follows a non-linear, accelerating pattern. Unlike periodontitis, which progresses in bursts of activity interspersed with periods of quiescence, peri-implantitis appears to progress more rapidly once established, with mean bone loss rates of 0.2-0.4 mm per year but wide individual variation. This aggressive progression is attributed to the absence of a periodontal ligament, which provides a barrier and regenerative capacity around natural teeth.

Risk Factors and Indicators

History of Periodontitis

A history of severe periodontitis is the strongest and most consistently identified risk factor for peri-implantitis. Patients with a history of periodontitis have a 3-5 fold higher risk of developing peri-implantitis compared to periodontally healthy individuals. This is attributed to the persistence of periodontal pathogens in the oral cavity, altered host immune response, and compromised tissue quality at implant sites. Meticulous supportive periodontal therapy is essential for these patients, but it does not eliminate the elevated risk entirely.

Smoking

Smoking is an established risk factor, with current smokers demonstrating a 2-3 fold increased risk of peri-implantitis compared to non-smokers. The mechanisms include impaired microcirculation, altered neutrophil function, increased pro-inflammatory cytokine production, and reduced fibroblast activity. Smoking cessation reduces but does not fully normalize the risk, and patients should be informed of these risks during treatment planning.

Inadequate Oral Hygiene and Compliance

Poor oral hygiene and irregular maintenance care are strongly associated with peri-implant disease. Studies consistently show that patients who do not attend regular supportive care visits have significantly higher rates of peri-implantitis. The compliance threshold appears to be at least annual recall, with higher frequency recommended for high-risk patients.

Diabetes Mellitus

Poorly controlled diabetes (HbA1c above 7%) is associated with an increased risk of peri-implantitis through mechanisms similar to those linking diabetes to periodontitis: impaired wound healing, altered collagen metabolism, advanced glycation end-product formation, and altered immune response. Well-controlled diabetes does not appear to significantly increase risk.

Other Risk Factors

Additional risk indicators include: excess cement from cement-retained restorations (a major iatrogenic cause), implant surface characteristics (moderately rough surfaces may harbor more biofilm), inadequate keratinized mucosa (though evidence is mixed), genetic polymorphisms (particularly in interleukin-1 genes), and certain medications such as selective serotonin reuptake inhibitors and proton pump inhibitors, which have been associated with increased implant failure rates.

Non-Surgical Management

Non-surgical mechanical debridement is the first-line treatment for peri-implant mucositis and mild to moderate peri-implantitis. The goal is to disrupt and remove the biofilm from the implant surface while minimizing surface damage that could facilitate future biofilm accumulation.

Instrumentation includes carbon fiber or plastic-tipped curettes, titanium scalers, ultrasonic tips with plastic or carbon fiber covers, and glycine or erythritol powder air polishing. Metallic instruments such as stainless steel curettes should be avoided as they scratch the implant surface, creating niches for bacterial colonization. Air polishing with glycine powder has emerged as particularly effective, achieving superior biofilm removal with less surface alteration compared to mechanical instrumentation alone.

Adjunctive therapies include locally delivered antibiotics (minocycline or doxycycline microspheres), systemic antibiotics (amoxicillin plus metronidazole for 7-10 days), chlorhexidine irrigation, and laser therapy (Er:YAG or diode). The evidence for adjunctive antibiotics is stronger than for non-surgical treatment alone, but complete resolution of deep peri-implantitis defects is rarely achieved without surgical intervention.

Systematic reviews indicate that non-surgical treatment reduces BOP by 30-50% and probing depths by 0.5-1.5 mm, but residual probing depths of 5 mm or greater commonly persist. The presence of a submucosal biofilm, complex implant surface topography, and limited access to implant threads restrict the effectiveness of closed debridement.

Surgical Management: Principles and Approaches

Surgical intervention is indicated when non-surgical treatment fails to resolve inflammation and deep probing depths persist, typically at sites with probing depths exceeding 5 mm and radiographic bone loss of 2 mm or more. The objectives of surgical treatment include: achieving visual access for complete debridement and decontamination of the implant surface, eliminating the inflammatory lesion, arresting progressive bone loss, and re-establishing a maintainable peri-implant environment.

Access Flap Surgery and Implant Surface Decontamination

Following full-thickness flap reflection and granulation tissue removal, the implant surface must be thoroughly decontaminated. No single decontamination protocol has been shown to be superior, and a combination of mechanical and chemical methods is typically employed. Mechanical debridement with titanium or plastic curettes and rotating titanium brushes is combined with chemical decontamination using 3% hydrogen peroxide, 0.12% chlorhexidine, 24% ethylenediaminetetraacetic acid (EDTA), or citric acid.

Laser decontamination, particularly with the Er:YAG laser, has shown promise in vitro for bacterial elimination and implant surface detoxification without thermal damage to surrounding tissues. However, clinical studies have not consistently demonstrated superiority over conventional mechanical and chemical decontamination.

Electrolytic cleaning systems, which electrochemically release hydrogen bubbles from the exposed implant surface to mechanically dislodge biofilm, represent a newer approach with encouraging preliminary results but limited long-term data.

Resective Surgery and Implantoplasty

Resective surgery involves osseous recontouring to eliminate the infraosseous defect component, combined with apically positioned flap repositioning to reduce probing depths. This approach is indicated for supracrestal and shallow infraosseous defects, particularly in non-aesthetic areas where increased soft tissue recession is acceptable.

Implantoplasty, the mechanical removal of the exposed implant threads and surface modification using rotary diamond or carbide burs under copious irrigation, is often performed in conjunction with resective surgery. By creating a smooth, machined-like surface on the exposed implant portion, implantoplasty reduces the surface area for biofilm accumulation and facilitates patient self-performed plaque control.

Concerns regarding implantoplasty include potential heat generation causing bone necrosis, titanium particle dissemination into surrounding tissues, and weakening of the implant body in narrow-diameter implants. The procedure is not recommended for implants with a diameter of 3.5 mm or less due to fracture risk.

Regenerative Surgery

Regenerative approaches aim to reconstruct the lost peri-implant bone and, ideally, achieve re-osseointegration on the previously contaminated implant surface. This approach is indicated for well-contained infraosseous defects, particularly in the aesthetic zone where soft tissue recession must be minimized.

The regenerative procedure involves flap reflection, thorough degranulation and implant surface decontamination, placement of a bone graft material (autogenous bone, deproteinized bovine bone mineral, or allograft) into the defect, and coverage with a resorbable collagen membrane. The implant surface decontamination step is critical, as residual bacteria on the implant surface will compromise regenerative outcomes.

Systematic reviews report that regenerative treatment of peri-implantitis defects achieves mean radiographic bone fill of 2-3 mm and probing depth reductions of 3-4 mm, with defect fill rates of 50-80%. However, complete defect resolution is less predictable than with guided bone regeneration at the time of implant placement, and true histologic re-osseointegration is achieved in only a minority of cases.

Explantation

In cases of severe peri-implantitis with advanced bone loss exceeding 50-60% of the implant length, implant mobility, or recurrent disease following surgical treatment, explantation is indicated. The decision to remove an implant should be made promptly when the prognosis is hopeless to preserve the remaining bone for potential future implant placement after ridge augmentation. Delayed removal leads to progressive bone loss that complicates subsequent reconstruction.

Maintenance and Long-Term Outcomes

Following successful peri-implantitis treatment, a structured maintenance program is essential. Supportive care intervals of 3-4 months are recommended for the first year, with subsequent intervals individualized based on risk assessment. Maintenance visits should include assessment of BOP, probing depths, suppuration, and radiographic evaluation at appropriate intervals.

Long-term studies of peri-implantitis treatment show that while most cases can be stabilized, complete disease resolution is uncommon. Approximately 70-80% of treated implants survive at 5-year follow-up, but residual BOP and probing depths of 5 mm or greater persist in up to 40% of cases. Recurrence of disease requiring re-treatment occurs in 15-25% of treated sites, emphasizing the chronic nature of the condition and the importance of ongoing maintenance.

Prevention: The Most Effective Strategy

Given the challenges and imperfect outcomes of peri-implantitis treatment, prevention is paramount. Effective preventive strategies include: comprehensive risk assessment before implant placement, establishing periodontal health prior to implant surgery, designing implant-supported restorations with accessibility for oral hygiene, using screw-retained restorations in patients with deep subgingival margins, and implementing a personalized supportive care program from the time of prosthesis delivery.

Patient education regarding peri-implant health and the critical importance of oral hygiene and regular professional maintenance cannot be overstated. Patients should understand that implants, like natural teeth, require lifelong care and that the consequences of neglect may be more severe given the aggressive nature of peri-implantitis.

Conclusion

Peri-implantitis is a prevalent, challenging, and potentially devastating complication of implant therapy. Diagnosis requires the combination of clinical signs of inflammation and radiographic evidence of progressive bone loss. While non-surgical treatment provides limited benefit for established lesions, surgical approaches including access flap debridement, resective surgery with implantoplasty, and regenerative procedures can arrest disease progression and extend implant survival. However, the outcomes are imperfect, and prevention through risk assessment, meticulous surgical and prosthetic execution, and rigorous maintenance remains the most effective strategy for preserving peri-implant health.